OCIFTY

Serial Number 97859256
606

Registration Progress

Application Filed
Mar 27, 2023
Under Examination
Mar 19, 2024
Approved for Publication
Jan 23, 2024
Published for Opposition
Jan 23, 2024
Registered

Trademark Image

OCIFTY

Basic Information

Serial Number
97859256
Filing Date
March 27, 2023
Published for Opposition
January 23, 2024
Abandonment Date
October 10, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 10, 2025
Classes
005

Rights Holder

BeiGene Switzerland GmbH

03
Address
Aeschengraben 27
Basel 4051
CH

Ownership History

BeiGene Switzerland GmbH

Original Applicant
03
Basel CH

BeiGene Switzerland GmbH

Owner at Publication
03
Basel CH

Legal Representation

Attorney
Kristen S. Ruisi

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Oct 10, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 10, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 1, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 1, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 1, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 1, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 19, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 21, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 20, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 18, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 30, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification

International Classes
005